DNA global hypomethylation in EBV-transformed interphase nuclei.

Area of Science:

• Oncology
• Molecular Biology
• Immunochemistry

Background:

• Tumor DNA often exhibits global hypomethylation compared to normal tissues.
• Traditional methods provide average DNA methylation values, masking cellular heterogeneity.
• A need exists for cell-specific analysis of DNA methylation in mixed cell populations.

Purpose of the Study:

• To develop and validate an immunochemical technique for detecting hypomethylated DNA on a cell-by-cell basis.
• To assess the feasibility of analyzing individual nuclei for DNA hypomethylation in heterogeneous samples.
• To compare DNA methylation levels between different cell types using this novel method.

Main Methods:

• Utilized monoclonal antibodies targeting 5-methylcytidine for labeling cells.
• Employed immunochemical staining with appropriate fixation and permeabilization for nuclei labeling.
• Analyzed labeled cells using flow cytometry and fluorescence microscopy.
• Confirmed findings with Southern transfer and hybridization of DNA fragments.

Main Results:

• Successfully labeled interphase nuclei with monoclonal antibodies to 5-methylcytidine.
• Detected quantitative differences in labeling between Epstein-Barr virus-transformed cells and normal monocytes.
• Flow cytometry and fluorescence microscopy revealed distinct methylation patterns.
• Results were corroborated by Southern blot analysis, confirming DNA hypomethylation in specific cell populations.

Conclusions:

• The developed immunochemical technique enables cell-by-cell detection of hypomethylated DNA.
• This method overcomes limitations of bulk analysis, providing insights into cellular heterogeneity.
• The approach is suitable for analyzing fresh tumor samples via flow cytometry and microscopy, advancing cancer research.